Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - AcademicCME

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.50

Already have an Account? Log In
Don’t have an account? Register Today

Recent Courses

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

Updating the Efficacy and Safety Experience of IL-17 Inhibitors